The CEO of Valeant pharmaceuticals stepped down today after the company faces questions about pricing; paint company Sherwin-Williams is buying competitor Valspar to expand its market overseas; and at Duke University, the latest group of adjunct professors want to unionize.
The CEO of Valeant pharmaceuticals stepped down today after the company faces questions about pricing; paint company Sherwin-Williams is buying competitor Valspar to expand its market overseas; and at Duke University, the latest group of adjunct professors want to unionize.